Back to search
Kalvista Pharmaceuticals Limited
07543947
active
Private Limited Company
england wales
Health Score
61 / 100
Some Concerns
25/30
Filing
0/30
Financial
36/40
Risk
- 2 outstanding charges (-4)
Details
C/O CSC CLS (UK) LIMITED 5 CHURCHILL PLACE, LONDON, E14 5HU
Incorporated 25/02/2011
Compliance
Last accounts
31/12/2025
full
Next accounts due
30/09/2027
On track
Confirmation statement
Last: 25/02/2026
Due 11/03/2027
On track
Industry
72190
Other research and experimental development on natural sciences and engineeringOfficers
Ms Laura Amy Lovell
secretary · Since 11/06/2026
Andrew Philip Dickinson
director · Since 11/06/2026
BRITISH · ENGLAND
Former
Csc Cls (Uk) Limited
corporate secretary · Resigned 11/06/2026
Persons with Significant Control
Kalvista Pharmaceuticals Inc.
75–100% shares
75–100% votes
Appoint directors
Notified 21/11/2016
Mr Alberto Chiesi
25–50% shares
25–50% votes
Italian · Italy
Notified 22/06/2026
Mr Alessandro Chiesi
Significant control
Italian · Italy
Notified 22/06/2026
Mr Giacomo Chiesi
Significant control
Italian · Italy
Notified 22/06/2026
Ms Maria Paola Chiesi
Significant control
Italian · Italy
Notified 22/06/2026
Mr Andrea Chiesi
Significant control
Italian · Italy
Notified 22/06/2026
Charges2 outstanding
A registered charge
satisfied
DRI HEALTHCARE ACQUISITIONS LP
Created 04/11/2024Registered 19/10/2026Satisfied 19/10/2026
A registered charge
satisfied
DRI UK LP
Created 23/10/2025Registered 19/10/2026Satisfied 19/10/2026
Charge
outstanding
DRI UK LP
Created 23/10/2025Registered 31/10/2025
Charge
outstanding
DRI HEALTHCARE ACQUISITIONS LP
Created 04/11/2024Registered 11/11/2024